enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. A Full List of Recalled Eye Drops Linked to Potential ... - AOL

   www.aol.com/full-list-recalled-eye-drops...

   Earlier in February, two distinct eye drop products were recalled and have been directly linked to a risk of bacterial infection — Artificial Tears Lubricant Eye Drops branded by EzriCare and ...

3. Over 27 Eye Drops Have Been Recalled: What You Need to Know - AOL

   www.aol.com/lifestyle/eye-drop-recall-know...

   [table-of-contents] stripped. It’s been a bad year for eye drops. The U.S. Food and Drug Administration (FDA) has issued yet another eye drop recall—this time focusing on 27 different over-the ...

4. Recent recalls, FDA warnings about eye care products are ...

   www.aol.com/lifestyle/recent-recalls-fda...

   A slew of recent recalls and warnings has called into question the safety of products designed to treat and maintain eye health. On Friday, the Food and Drug Administration warned consumers not to ...

5. Artificial tears - Wikipedia

   en.wikipedia.org/wiki/Artificial_tears

   Artificial tears. A subset of various brands of artificial tears displayed in a store. Specialty. ophthalmology. [ edit on Wikidata] Artificial tears are lubricating eye drops used to relieve dryness and irritation of the ocular surface. [1] Dry eye syndrome ( keratoconjunctivitis sicca) is a common ocular surface disorder and is characterized ...

6. Tropicamide - Wikipedia

   en.wikipedia.org/wiki/Tropicamide

   Tropicamide, sold under the brand name Mydriacyl among others, is a medication used to dilate the pupil and help with examination of the eye. [3] Specifically it is used to help examine the back of the eye. [4] It is applied as eye drops. [3] Effects occur within 40 minutes and last for up to a day.

7. 2022–2023 United States P. aeruginosa outbreak in eye drops

   en.wikipedia.org/wiki/2022–2023_United_States_P...

   outbreak in eye drops. The 2022–2023 United States Pseudomonas aeruginosa outbreak began in May 2022, with the infection of several patients in California. The Centers for Disease Control and Prevention (CDC) became aware of a strain of Pseudomonas aeruginosa in artificial tears manufactured by EzriCare and Delsam Pharma in January 2023.